×
Adagio Medical Holdings Price to Free Cash Flow Ratio 2020-2024 | ADGM
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
PE Ratio
P/S Ratio
Price/Book Ratio
Price-FCF Ratio
Net Worth
Adagio Medical Holdings price to free cash flow ratio from 2020 to 2024. Price to free cash flow ratio can be defined as
View More
Adagio Medical Holdings Price to Free Cash Flow Ratio 2020-2024 | ADGM
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
PE Ratio
P/S Ratio
Price/Book Ratio
Price-FCF Ratio
Net Worth
Adagio Medical Holdings price to free cash flow ratio from 2020 to 2024. Price to free cash flow ratio can be defined as
Related Stocks
Company Name
Market
Cap
Thermo Fisher Scientific (TMO)
$234.6B
Intuitive Surgical (ISRG)
$174.6B
Alcon (ALC)
$48.6B
IQVIA Holdings (IQV)
$43.6B
IDEXX Laboratories (IDXX)
$42.1B
Edwards Lifesciences (EW)
$41.8B
DexCom (DXCM)
$28.1B
STERIS (STE)
$24B
SONOVA HOLDING (SONVY)
$21.5B
Waters (WAT)
$19.5B
Hologic (HOLX)
$19.2B
Sysmex ADR (SSMXY)
$12.3B
Fresenius Medical Care AG KGaA (FMS)
$12.3B
Teleflex (TFX)
$11.6B
Globus Medical (GMED)
$9.5B
Penumbra (PEN)
$7.3B
Glaukos (GKOS)
$6.8B
Masimo (MASI)
$6.1B
TransMedics (TMDX)
$5B
Integer Holdings (ITGR)
$4.3B
PROCEPT BioRobotics (PRCT)
$4.3B
Tandem Diabetes Care (TNDM)
$2.8B
Inari Medical (NARI)
$2.7B
LivaNova (LIVN)
$2.6B
Nihon Kohden (NHNKY)
$2.6B
Veracyte (VCYT)
$2.6B
Elekta AB (EKTAY)
$2.4B
RxSight (RXST)
$2.1B
Integra LifeSciences Holdings (IART)
$1.3B
Pulse Biosciences (PLSE)
$1.2B